The scientific muscle of Brazil's health biotechnology

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Brazilian publications and USPTO patents in health biotechnology (1991–2002).

Illustration by R. Henretta

References

  1. 1

    Rebêlo, P. SciDev.Net, 16 June 2004. http://www.scidev.net

  2. 2

    World Health Organization and International Diabetes Foundation. Diabetes Action Now (WHO, Geneva, Switzerland, 2004). http://www.who.int/diabetes/actionnow/booklet/en/

  3. 3

    United Nations Conference on Trade and Development. UNCTAD Handbook of Statistics Online (UNCTAD, Geneva, 2003). http://www.unctad.org/Templates/StartPage.asp?intItemID=2068

  4. 4

    International Business Strategies. The Biotechnology Market in Brazil (International Business Strategies, Los Gatos, CA, USA, 2003).

  5. 5

    Science-Metrix. Benchmarking of Genomics and Health Biotechnology in Seven Developing Countries, 1991–2004. Report Prepared for University of Toronto, Joint Centre for Bioethics (Science-Metrix, Quebec, 2004). Data derived from information (subset of Science Citation Index Expanded Database) Prepared by the Institute for Scientific Information (ISI, Philadelphia, PA, USA). © Institute for Scientific Information. All rights reserved.

  6. 6

    Oda, L.M., Correa Soares, B.E. & Valadares-Inglis, M.C. in Biotechnology in the Developing World and Countries in Economic Transition (eds. Tzotzos, G.T. & Skryabin, K.G.) 43–52 (CAB International, Wallingford, UK, 2000).

    Google Scholar 

  7. 7

    http://www.inpi.gov.br

  8. 8

    http://www.anvisa.gov.br

  9. 9

    Bernardes Marques, M. Int. J. Biotechnol. 5, 38–46 (2004).

    Article  Google Scholar 

  10. 10

    Massarani, L. SciDev.Net, 13 October 2004. http://www.scidev.net

  11. 11

    de Oiveira, W. SciDev.Net, 12 November 2003. http://www.scidev.net

  12. 12

    Coura, J.R. Mem. Inst. Oswaldo Cruz 95, 9–16 (2000).

    Article  Google Scholar 

  13. 13

    http://aeg.lbi.ic.unicamp.br/xf/

  14. 14

    UK Trade and Investment. Biotechnology and Pharmaceutical Market in Brazil. http://www.uktradeinvest.gov.uk/biotechnology/brazil/profile/overview.shtml (2003).

  15. 15

    Mani, S. Government, Innovation and Technology Policy: An International Comparative Analysis (Edward Elgar, Cheltenham, 2002).

    Google Scholar 

  16. 16

    http://www.adunicamp.org.br/noticias/universidade/leideinova%E7%E3o.pdf

  17. 17

    http://www.forbes.com/technology/ebusiness/feeds/ap/2004/08/31/ap1525328.html

  18. 18

    Cruvinel, T. A lei da inovação. Panorama Político O Globo, July 3, 2004.

  19. 19

    Mantell, K. SciDev.Net. 28 February 2002. http://www.scidev.net

  20. 20

    Simpson, A.J. et al. Nature. 406, 151–157 (2000).

    CAS  Article  Google Scholar 

  21. 21

    http://www.wipo.int/sme/en/case_studies/fk_biotec.htm

Download references

Acknowledgements

Publication of this supplement was supported by the Bill and Melinda Gates Foundation (Seattle, WA), Genome Canada (Ottawa, ON, Canada), McLaughlin Centre for Molecular Medicine (Toronto, Canada) and the Rockefeller Foundation (New York, NY). We want to thank Natalia Ramos Miranda for her cooperation and help with bibliographic searches and analysis of background documents. Thanks to Archana Bhatt, Zoe Costa-von Aesch and James Renihan for patent analysis, Éric Archambault, Frédéric Bertrand and Grégoire Côté at Science-Metrix (Montréal, Canada) for analysis of publication data and also to Carlos More and Fabio Salamanca-Buentello for their valuable input, as well as the Brazilian experts who kindly agreed to be interviewed, thereby making it possible to carry out this study. The Canadian Program on Genomics and Global Health is primarily supported by Genome Canada through the Ontario Genomics Institute and by the Ontario Research and Development Challenge Fund. Matching funders are listed at http://www.geneticsethics.net. P.A.S. is supported by a Canadian Institutes of Health Research Distinguished Investigator award. A.S.D. is supported by the McLaughlin Centre for Molecular Medicine, University of Toronto.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Halla Thorsteinsdóttir.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ferrer, M., Thorsteinsdóttir, H., Quach, U. et al. The scientific muscle of Brazil's health biotechnology. Nat Biotechnol 22, DC8–DC12 (2004). https://doi.org/10.1038/nbt1204supp-DC8

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing